Retransplantation after post-transplant lymphoproliferative disease

Pediatric Nephrology

Volumn 11, Issue 3, 1997, Pages 358-360

  Demircin, Gülay ^a,b   Rees, Lesley ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b NONE   (Turkey)

Author keywords

Epstein Barr virus; Post transplant lymphoproliferative disease; Retransplantation

Indexed keywords

IMMUNOGLOBULIN; PREDNISOLONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS; DIALYSIS; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPTICEMIA;

ADOLESCENT; HUMANS; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; PSEUDOMONAS INFECTIONS; REOPERATION; SEPSIS;

EID: 0030969173     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050297     Document Type: Article

References (12)

1. Momson VA, Dunn DL, Manivel JC, Gajil-Peczalska KJ, Peterson BA (1994) Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med 97: 14 - 24
2. Lebland V, Suttan L, Dorent R, Davi F, Bitker MO, Gabarre J, Charlotte F, Ghoussoub JJ, Fourcade C, Fischer A, Gandjbakhch I, Binet JL, Raphael M (1995) Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center J Clin Oncol 13. 961 - 968
3. Reyes J, Tzakis AG, Bonet H, Green M, Yunis E, Nalesnik M, Nour B, Kocoshis S, Abu-Elmagd K, Todo S, Starzl TE (1994) Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. Transplant Proc 26: 1426 - 1427
4. Craig FE, Gulley ML, Banks PM (1993) Posttransplantation lymphoproliferative disorders. Am J Clin Pathol 99: 265 - 276
5. Benkerrou M, Durandy A, Fischer A (1993) Therapy for transplant-related lymphoproliferative diseases. Hematol Oncol Clin North Am 7: 467 - 475
6. Garret TJ, Chadburn A, Barr ML, Drusin RE, Chen JM, Schulman LL, Smith CR, Reison DS, Rose EA, Michler RE, Knowles DM (1993) Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy. Cancer 72: 2782 - 2785
7. Hickey DP, Nalesnik MA, Vivas CA, Lopatin WB, Jordan ML, Starzl TE, Hakala TR (1990) Renal retransplantation in patients who lost their allografts during management of previous posttransplant lymphoproliferative disease. Clin Transplant 4: 187 - 190
8. Hanto DW (1995) Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies. Annu Rev Med 46: 381 - 394
9. Preiksaitis JK, Diaz-Mitoma F, Mirzayans F, Roberts S, Tyrell DLJ (1992) Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder. J Infect Dis 166. 986 - 994
10. Sokal EM. Caragiozoglou T, Lamy M, Reding R, Otte JB (1993) Epstein-Barr virus serology and Epstein-Barr virus associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation 56: 1394 - 1398
11. Riddler SA, Breinig MC, McKnight JLC (1994) Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 84: 972 - 984
12. Chen JM, Barr ML, Chadburn A, Frizzera G, Schenkel FA, Sciacca RR, Reison DS, Addonizio LJ, Rose EA, Knowles DM, Michler RE (1993) Management of lymphoproliferative disorders after cardiac transplantation. Ann Thorac Surg 56: 527 - 538